Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WWE
426
DELISTED
World Wrestling Entertainment
WWE
| $40.2M | 0.06% |
463,450
+274,531
| +145% | +$23.1M |
|
427
Sun Communities
SUI
$14.8B
| $39.7M | 0.06% |
335,061
-217,705
| -39% | -$24.2M |
|
428
PUT
Lennox International
LII
$13.9B
| $39.7M | 0.06% |
+150,000
| New | +$35.9M |
|
|
NVO
429
Novo Nordisk
NVO
$207B
| $39.6M | 0.06% |
1,513,684
-143,858
| -9% | -$3.54M |
|
|
MXIM
430
DELISTED
Maxim Integrated Products
MXIM
| $39.5M | 0.06% |
742,951
-713,962
| -49% | -$38.4M |
|
431
Takeda Pharmaceutical
TAK
$58.1B
| $39.5M | 0.06% |
1,939,209
+1,926,409
| +15,050% | +$38.8M |
|
432
TG Therapeutics
TGTX
$8.31B
| $39.4M | 0.06% |
4,905,786
+4,786,175
| +4,001% | +$25.9M |
|
433
Steel Dynamics
STLD
$32.8B
| $39.4M | 0.06% |
1,117,080
-1,624,906
| -59% | -$57.7M |
|
434
Vornado Realty Trust
VNO
$7.07B
| $39.2M | 0.06% |
581,227
+558,093
| +2,412% | +$37.4M |
|
435
TechnipFMC
FTI
$30.4B
| $39.2M | 0.06% |
2,238,576
+1,191,003
| +114% | +$20.1M |
|
436
Southwest Airlines
LUV
$19.8B
| $38.9M | 0.06% |
750,063
-3,842,194
| -84% | -$203M |
|
|
GHDX
437
DELISTED
Genomic Health, Inc.
GHDX
| $38.9M | 0.06% |
555,700
-62,487
| -10% | -$4.63M |
|
438
Pultegroup
PHM
$24.6B
| $38.8M | 0.06% |
1,388,026
-2,714,075
| -66% | -$74M |
|
439
West Pharmaceutical
WST
$24.8B
| $38.8M | 0.06% |
352,016
+200,268
| +132% | +$20.8M |
|
440
Coca-Cola Europacific Partners
CCEP
$47.7B
| $38.8M | 0.06% |
749,598
-588,465
| -44% | -$27.9M |
|
|
JNPR
441
DELISTED
Juniper Networks
JNPR
| $38.5M | 0.06% |
1,452,968
-173,998
| -11% | -$4.69M |
|
442
Avista
AVA
$3.15B
| $38.4M | 0.06% |
944,951
+885,662
| +1,494% | +$36.4M |
|
443
Live Nation Entertainment
LYV
$42.4B
| $38.4M | 0.06% |
603,659
+442,042
| +274% | +$25.1M |
|
444
Dropbox
DBX
$7.5B
| $38.3M | 0.06% |
1,758,379
+958,571
| +120% | +$22.3M |
|
445
PUT
State Street SPDR S&P Retail ETF
XRT
$491M
| $38.3M | 0.06% |
+851,000
| New | +$37.8M |
|
446
Encompass Health
EHC
$11.9B
| $38.3M | 0.06% |
824,217
+475,508
| +136% | +$24.1M |
|
447
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $38.3M | 0.06% |
454,733
-17,368
| -4% | -$1.45M |
|
448
Saic
SAIC
$5.41B
| $38.2M | 0.06% |
495,794
+488,642
| +6,832% | +$34.4M |
|
449
Fortune Brands Innovations
FBIN
$5.32B
| $38.1M | 0.06% |
936,642
+60,073
| +7% | +$2.31M |
|
450
PUT
Adobe
ADBE
$109B
| $38.1M | 0.06% |
143,000
+74,900
| +110% | +$18.9M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.